These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28126979)

  • 1. [Myotonic Dystrophy: Advances in Translational Research].
    Nakamori M; Takahashi MP
    Brain Nerve; 2017 Jan; 69(1):61-69. PubMed ID: 28126979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myotonic dystrophy: therapeutic approaches to RNA toxicity].
    Nakamori M; Takahashi MP
    Brain Nerve; 2011 Nov; 63(11):1161-8. PubMed ID: 22068468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myotonia and cardiac conduction defects in myotonic dystrophy and defect in ion channels].
    Kubota T; Nakamori M; Takahashi MP
    Rinsho Byori; 2014 Mar; 62(3):246-54. PubMed ID: 24800500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentamidine reverses the splicing defects associated with myotonic dystrophy.
    Warf MB; Nakamori M; Matthys CM; Thornton CA; Berglund JA
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18551-6. PubMed ID: 19822739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challenges.
    Sicot G; Gourdon G; Gomes-Pereira M
    Hum Mol Genet; 2011 Oct; 20(R2):R116-23. PubMed ID: 21821673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular therapy in myotonic dystrophy: focus on RNA gain-of-function.
    Mulders SA; van Engelen BG; Wieringa B; Wansink DG
    Hum Mol Genet; 2010 Apr; 19(R1):R90-7. PubMed ID: 20406734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing levels of toxic RNA with small molecules.
    Coonrod LA; Nakamori M; Wang W; Carrell S; Hilton CL; Bodner MJ; Siboni RB; Docter AG; Haley MM; Thornton CA; Berglund JA
    ACS Chem Biol; 2013 Nov; 8(11):2528-37. PubMed ID: 24028068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic development in myotonic dystrophy].
    Takahashi MP; Nakamori M; Mochizuki H
    Rinsho Shinkeigaku; 2014; 54(12):1077-9. PubMed ID: 25519965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscleblind-like 2 (Mbnl2) -deficient mice as a model for myotonic dystrophy.
    Hao M; Akrami K; Wei K; De Diego C; Che N; Ku JH; Tidball J; Graves MC; Shieh PB; Chen F
    Dev Dyn; 2008 Feb; 237(2):403-10. PubMed ID: 18213585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myotonic dystrophies: An update on clinical aspects, genetic, pathology, and molecular pathomechanisms.
    Meola G; Cardani R
    Biochim Biophys Acta; 2015 Apr; 1852(4):594-606. PubMed ID: 24882752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
    Klein AF; Gasnier E; Furling D
    Biochimie; 2011 Nov; 93(11):2006-12. PubMed ID: 21763392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy.
    Wojtkowiak-Szlachcic A; Taylor K; Stepniak-Konieczna E; Sznajder LJ; Mykowska A; Sroka J; Thornton CA; Sobczak K
    Nucleic Acids Res; 2015 Mar; 43(6):3318-31. PubMed ID: 25753670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA pathogenesis of the myotonic dystrophies.
    Day JW; Ranum LP
    Neuromuscul Disord; 2005 Jan; 15(1):5-16. PubMed ID: 15639115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for alternative splicing of insulin receptor in myotonic dystrophy type 1.
    Tonevitsky EA; Trushkin EV
    Bull Exp Biol Med; 2009 Jun; 147(6):772-6. PubMed ID: 19902080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myotonic dystrophy: RNA-mediated muscle disease.
    Wheeler TM; Thornton CA
    Curr Opin Neurol; 2007 Oct; 20(5):572-6. PubMed ID: 17885447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular Senescence and Aging in Myotonic Dystrophy.
    Hasuike Y; Mochizuki H; Nakamori M
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.
    Cardani R; Mancinelli E; Rotondo G; Sansone V; Meola G
    Eur J Histochem; 2006; 50(3):177-82. PubMed ID: 16920640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular pathways to myotonic dystrophy].
    Ishiura S
    Nihon Rinsho; 2005 Mar; 63(3):515-21. PubMed ID: 15773354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.